In 1973, Vidal published a paper titled 'Toward direct brain-computer communication' in the Annual Review of Biophysics and Bioengineering, discussing the potential of direct communication between the brain and computers.

In 1977, J. Vidal presented a paper titled 'Real-Time Detection of Brain Events in EEG' in the IEEE Proceedings, focusing on the real-time detection of brain events in EEG signals.

In 1997, preliminary activities related to Neuralink research took place.

Dr. Richard Norman at the University of Utah develops the Utah electrode array, a tiny piece of silicon with 256 electrodes that can be attached to the central nervous system to listen to neural activity.

Neuroscientists first pioneered the use of neural-brain interfaces on primates in 2002, allowing them to control objects on screens. This technological advancement laid the groundwork for subsequent developments in the field of neurobiology and brain-computer interfaces.

The comparative chart displays Google Trends data for Neuralink, The Boring Company, and OpenAI from January 2004 to March 2021. It also includes interest rankings by country and a world map display.

In 2009, Raymond Kurzweil predicted that scientists would have reverse-engineered, modeled, and simulated all the regions of the brain, providing humans with the software and algorithmic methods to simulate all of the human brain's capabilities, including emotional intelligence.

The chart presents Google Ngram Viewer data for Neuralink from 2010 to 2019.

Emotiv, a US-based bioinformatics company, was founded in 2011. It focuses on understanding the human brain using electroencephalography (EEG) and later became one of the top competitors of Neuralink.

BrainCo is founded and launches its brain-machine interface (BMI) technology products, including sensors, hardware, software, and AI. It later becomes a top competitor of Neuralink.

On April 20, 2017, a review related to Neuralink was conducted, possibly discussing the company's advancements or achievements.

A brief guide to Neuralink, Elon Musk's innovative brain-implant venture, was published, offering insights into the company's objectives and operations.

Elon Musk confirms plans for Neuralink, a company aiming to merge computers with brains, with the goal of enabling humans to engage in 'consensual telepathy' in the future.

Elon Musk tweeted that Neuralink is not seeking investors, indicating the company's independent funding approach.

Elon Musk hinted at Neuralink's plan to introduce microcontrollers to advance computer-brain interface technology, possibly leading to the unveiling of an initial version of what will eventually become a 'neural lace.'

Elon Musk's company Neuralink will be livestreaming a special project update on July 16th. The event is anticipated to reveal new developments and advancements in the field of brain-machine interfaces.

Neuralink is a brain interface startup founded by Elon Musk. It aims to develop technology that merges the human brain with artificial intelligence. The company's goal is to enhance human capabilities through the integration of technology with the brain.

Neuralink announced its ambitious plan to implant chips in human brains by 2020, indicating a major technological advancement and potential ethical implications.

On August 28, 2019, Elon Musk made a notable comment during an interview, expressing his concern that computers are advancing so rapidly that they could soon surpass human intelligence in every aspect.

The report 'Elon Musk's Neuralink Startup Planned to Test on Animals' was retrieved from inverse.com on 23 September 2019. It claims that Neuralink planned to conduct tests on animals.

Elon Musk's latest interview with Axios took place on November 25th. The interview likely covered a wide range of topics, potentially including updates on Neuralink and other ventures.

Alan Mardinly's LinkedIn profile was accessed or reviewed on this date, suggesting potential professional or networking activities.

A Neuralink brain chip was demonstrated to work in a pig, indicating a successful milestone in the company's technological advancements.

Neuralink, The Boring Company, and OpenAI were trending on Google on 19th March 2021.

References to Neuralink were found in books retrieved on 22nd March 2021.

Max Hodak, the co-founder and president of Neuralink, announced in May 2021 that he had left the company in April 2021. He expressed his continued support for Neuralink despite his departure.

Neuralink announced raising a $205 million series C funding round from investors, including Google's GV. The company revealed that the first commercial application of its chip could be to assist quadriplegic individuals in regaining digital freedom.

Elon Musk announced at The Wall Street Journal CEO Council Summit that Neuralink hoped to start human testing the following year, pending FDA approval. He reiterated this claim on Twitter, expressing that progress would accelerate when devices are implanted in humans.

A January 2022 article in Fortune highlighted criticism of Neuralink's corporate culture, describing a 'culture of blame and fear' and vacillating priorities among employees.

In February 2022, Max Hodak revealed that he had been serving as an advisor to Synchron, a rival biotech company, and had invested in it. He emphasized that his involvement with Synchron was not intended to undermine Neuralink.

Synchron, a brain-computer interface company, implanted its device in the first US patient in July 2022, putting the company’s implant on a path toward possible regulatory approval for wider use in people with paralysis.

As of September 2022, Neuralink had experienced internal conflict and staffing changes, reflecting challenges in managing the company's growth and scientific development.

Elon Musk announced the start of human clinical trials for Neuralink's Precise Robotically Implanted Brain-Computer Interface (PRIME) study. The technology aims to enable people with paralysis to control external devices using their thoughts.

On May 25, 2023, Elon Musk's Neuralink received FDA approval for human trials. Although recruitment for clinical trials had not yet opened, the company stated that details were expected soon.

Neuralink Corp., Elon Musk’s brain-implant company, announced that it has received approval from the US Food and Drug Administration to conduct human clinical trials for its brain-computer interface device. The device aims to help people with paralysis or traumatic brain injuries communicate and control a computer using only their thoughts.

Neuralink, Elon Musk's brain implant company, achieved a significant milestone by receiving FDA approval for human trials. The company's history includes key events such as hiring a neurosurgeon to develop a surgical robot and successful testing on animals.

The article provides an update on Neuralink's AI/ML hardware. It includes a disclaimer stating that the information presented is not intended as investment advice and reflects the views of Contrary LLC at a specific time.

On January 29, 2024, Elon Musk announced that Neuralink had successfully implanted a Neuralink device in a human, signifying a major achievement in its technological advancement.

Elon Musk announced that the first human patient of Neuralink can control a computer mouse using their thoughts, showcasing the advancement of neural-interface technology developed by the company.

The first human trial of the brain implant developed by Neuralink begins, aiming to enable individuals with paralysis to control external devices using their thoughts.

Neuralink introduced the first human trial participant, Noland Arbaugh, who demonstrated the ability to control a computer mouse through thought, showcasing the potential of the Neuralink implant.

Elon Musk announced that the first human patient received a Neuralink brain implant and was recovering well. The early results showed promising neuron spike detection. The first product, called Telepathy, was introduced to enable control of devices just by thinking, primarily for users who have lost the use of their limbs.

Elon Musk announced that the Neuralink patient could control a computer mouse using their thoughts, demonstrating the progress of the brain implant technology.

Elon Musk announced that the first human Neuralink patient had made a full recovery, demonstrating positive progress in the patient's neural effects. The patient was able to move a mouse around the screen and the company was working on further advancements.